Anda belum login :: 23 Nov 2024 00:06 WIB
Detail
BukuCytotoxic potentiation of vinblastine and paclitaxel by L-canavanine in human cervical cancer and hepatocellular carcinoma cells (article of Phytomedicine Vol.22 Iss.14, Dec 2015, p.1232-1237
Bibliografi
Author: Nurcahyanti, Agustina Dwi Retno ; Wink, Michael
Topik: L-canavanine; Vinblastine; Paclitaxel; Microtubule; Argininosuccinate synthase; Synergy; JABFUNG-FKIK-ADRN-2022-01
Bahasa: (EN )    
Penerbit: Elsevier     Tahun Terbit: 2015    
Jenis: Article - diterbitkan di jurnal ilmiah internasional
Fulltext: B1 Publikasi Rev Bu Agustin.pdf (4.07MB; 3 download)
Abstract
Background
The non-protein amino acid L-canavanine (L-CAV), found in several plants of the family Fabaceae is an antimetabolite which shows anticancer activity due to its ability to be incorporated into protein in the place of its analogue, L-arginine (L-ARG), leading to the alteration of the 3D conformation of newly synthesised proteins and usually a loss of their function.

Purpose
In this study, the ability of L-CAV to potentiate the cytotoxicity of microtubule- targeting drugs used in the chemotherapy of cancer, vinblastine (VIN) and paclitaxel (PTX) was evaluated.

Material and methods
The following cancer cells grown in arginine-rich and arginine-free media were employed: HeLa, Hep G2 and SK-HEP-1. Drug combination experiment used a method based on the median-effect principle and mass-action law.

Results
We observed that L-CAV, which is hardly toxic alone, potentiated the cytotoxicity of VIN and PTX in HeLa and hepatocellular carcinoma cells.

Conclusion
This is the first study showing the cytotoxic potentiation of microtubule-targeting drugs by L-CAV. The mechanism of synergy and animal studies need to be investigated further to see whether L-CAV might become an adjuvant in cancer treatment.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Lihat Sejarah Pengadaan  Konversi Metadata   Kembali
design
 
Process time: 0.15625 second(s)